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Synchronous fluorescence spectroscopy hasbeencombined withimmunoaffinity chromatography (IAC) andHPLC
to detect polycyclic aromatic hydrocarbon (PAH)-DNA adducts and measurer-7,t4-8dihydroxy-t-9, 10-epoxy-7,8,9,10-
tetrahydrobenzo[alpyrene (BPDE)-DNAadducts inhumantimues andcells. Amonockoal antibody (8E:1) thatrecognizes
arangeofPAH-DNAadducts, butnotchemiallyunrelatedadducts,wasusedtoprepareIACcolumns. SamplesofDNA
(25fromhumanlungand8positiveandnegativecontrols) werehydrolyzedenzymically andsubjectedtoIAC. Adducts
capturedbytheantibodiesandelutedinNaOH(50mM)wereanalyzedforfluorescentproperties. Thespectral fluorescence
excitation-emissionmatricessuggestedthepresenceofmixturesofPAH-DNAadductsinsomeoftheeluates. Theeluates
weresubsequentlyhydrolyzedwithacid(HCI,0.1 N,3hr)andreanalyzedbysynchronousfluorescencespechtscopyusing
awavelengthdifferentialof34nm. In6ofthe25humanlungDNAsamples, materialswithHPLC retentiontimesiden-
tical tobenzo[alpyrene-7,10/8,9-tetrahydrotetrol werefoundtohavefluorescencecharacteristicsindistinguishablefrom
pyrene. ComparisonswithappropriatestandardsindicaitedthatBPDE-DNAadductlevelswerebetween 1and40adducts
in10'unmodifiednucleotides. NocorrelationwasobservedbetweenlungDNA-adductlevelsandmeasuresofrecentsmok-
ing(serumcotinine), buttissuesamplestakenfrxm differentportonsofthesamehmgsshowedvariationintheDNAadduct
levelsdetected.Thisfindingcomplicatesinterpretation ofthedataandhasimportantimpliationsforthedesignoffuture
experiments.
Introduction
Polycyclic aromatic hydrocarbons (PAHs) form amajorclass
ofenvironmental pollutants; many ofthese compounds can be
metabolized and activated to carcinogenic species that bind
covalently with DNA (1). To measure genotoxic damage from
PAHs, fluorescence techniques have been developed for the
detection ofDNA adducts, and r-7,t-8-dihydroxy-t-9,10-epoxy-
7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE)-DNA adducts have
been identified inhumantissues (2). Our strategyfordetection
andchemicalcharacterizationofadducts isbased oncombining
the followingpreparative andanalytical procedures: immunoaf-
finitychromatography isusedtoconcentrateadductsofaspecific
chemical class (PAHs); HPLC facilitates separation of DNA
hydrolysis products; and synchronousfluorescence spectroscopy
(SFS), second derivative synchronous fluorescence spec-
troscopy, andthegeneration offluorescence excitation-emission
matrices (FEEMs) provide chemically specific detection
systems. Using this strategy (3,4), levels ofBPDE-DNAadducts
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in the range of 1-40 in 108 nucleotides have been measured in
human lung.
Materials and Methods
HumanlungswerecollectedatautopsyfromtheDepartment
of Anatomic Pathology, University ofMaryland. The tissues
were stored at -70°C until DNA was extracted according to a
previouslydescribedmethodology (5). EnzymicdigestsofDNA
wereapplied to immunoaffinity columnscontainingmonoclonal
antibodiesdirectedagainstBPDE-modifiedguanosine(6). The
columns werethen washedextensively withbuffer, and bound
materials were eluted with NaOH. Fractions eluted in NaOH
werefurtherhydrolyzedwithHCI, andFEEMsweregenerated
inthesynchronous mode. Products oftheacidhydrolysis were
then separated by HPLC. Materials with retentiontimes equal
tothoseofbenzo[a]pyrene-7,10/8,9-tetrahydrotetrol werefurther
subjected toSFSusing awavelengthdifference(aX) of34 nm.
Serum was obtained fromdonors andassayed forthe presence
ofcotinineusing aradioimmunoassay (7).
Results and Discussion
Synchronous fluorescence spectroscopyishighlyspecificfor
identification of aromatic nuclei because characteristic fluo-WESTONETAL.
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FIGURE 1. Contour plots showing fluorescence spectral excitation-emission
matrices for extracts ofhuman peripheral lung DNA (sample no. 1069).
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FIGURE 2. Contour plots showing fluorescence spectral excitation-emission
matrices for extracts ofhuman peripheral lung DNA (sample no. 1177).
rescence emissions can bedetected when the distance between
the excitation and emission monochromators is equal to the
Stokes-shift of a given chemical compound (8). This is par-
ticularly useful inthe caseofpyrenebecause the Stokes-shift is
large (28 nm). In addition, generation ofFEEMs can demon-
strate the presence ofpreviously uncharacterized materials in
complex mixtures. Figures 1 and 2 show FEEMs generated by
SFS for materials isolated from human lung DNAby immuno-
affinity chromatography (IAC) using the 8E11 antibodies. As
these FEEMs aredisplayed as contourplots, themajorfeatures
are indicated by fluorescence emission peaks in the region
290-350 nm for a range ofAX values between 40 and 100 nm.
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FIGURE 3. DNA samples were hydrolyzed with micrococcal nuclease. Ad-
ducts wereconcentrated by immunoaffinity chromatography (antibody 8EII)
thenhydrolyzed(0.1 NHCI)totetrahydrotetrols. Organic solventextractsof
theacid hydroysates weresubjected to HPLC, and materials with retention
timesidenticaltobenzo[a]pyrene-7,10/8,9-tetrahydrotetrol wereanalyzedby
synchronous fluorescence spectroscopy. (A) Zero-order synchronous
fluorescence spectrum generated for an extract ofhuman lung DNA (125
fmole isolated from sample no. 1132) (1 mg). (B) Corresponding second
derivative spectrum.
Thecomplexityofthesematricessuggeststhepresenceofmul-
tiple aromatic adducts in lung samples. The presence of the
pyrene fluorophore (indicating BPDE-DNA adducts in the
original DNA sample) is shown in Figure 1 by a fluorescence
emissionpeakat379 nm(AX34 nm); however, this signal does
notdominatethematrix. Inthese studies, specificity is obtain-
edthroughthechromatographic proceduresandselectionofthe
fluorescenceparameters. Specificity isconfirmedbythequali-
ty of the spectra observed. Fluorescent emissions from the
pyrenefluorophorearenotalwaysobviousuponFEEManalysis
ofa complex mixture, as shown in Figure 2. However, HPLC
separation ofthe acid hydrolysate from which this FEEM was
generatedrevealedaclearsignal, specificforpyrene, whenap-
propriate fractions wereanalyzed by SFS using AX 34 nm.
UsingbothSFSAX34nmandsecondderivativespectroscopy
to analyze HPLC eluates of the hydrolysis products of 1AC-
concentrated adducts, the levels ofBPDE-DNA adducts were
determined for 25 lung samples. The zero-order and second-
derivative synchronous fluorescence spectra (AX 34 nm) for
materialsisolatedfromhumanlungbyIACandHPLCareshown
in Figure 3. The presenceofspecific spectral signals (379 nm,
emissionX)andabsenceofothernonspecificsignalsindicatethat
theisolateispure. Inpreviousstudiestheidentityofthismaterial
as apure isolate ofthebenzo[a]pyrene-7,10/8,9-tetrahydrotetrol
was confirmed by GC-MS (4,9).
The levels of BPDE-DNA adducts detected in human pe-
ripherallungsamples(Table 1)weredeterminedbycomparison
withastandardcurvethatwaspreparedfromfluorescencepeak
heightsgeneratedbyanauthentictetrolstandardandradiolabeled
positivecontrolsamplesthatwereassayedtogetherwithhuman
samples to account for efficiency ofthe preparative procedure
(Table 1). Tetrol recovery from 3H-BPDE-modified DNA
samplesrangedfrom26to66% forthewholeprocedure. Assays
were performed on coded sample sets that consisted of 4-20
human DNAsamplesandatleast2positiveand2negative con-
trol samples. Humanperipheral lungDNA wasassayed from a
total of 25 individuals. There was sufficient tissue to in-
dependentlyextractDNAfrom 12ofthelungsamplestwiceand
4 of them 3 times. Lung DNA from six individuals contain-
ed BPDE-DNA adduct levels between 23 and 1215 amole/
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Table 1. Levelsofserumcotinine, demographic data, andbenzo[alpyrene
(BaP) adduct levels in lungs of autopsy donors from the Baltimore,
Maryland, areaofthe United States.
Case Cotinine, BaP adducts
no. A/G/Ra ng/mL I II III
1069 44/M/W 414 75 151 36
1132 24/M/W SNCC 125 289 NDd
1128 45/F/B 245 29 71
1177 21/M/W 52 35 1215
1119 42/M/B SNC 23
1143 17/M/B ND 35
Controls, %V 42-66 26-40 42-63
1Age/gender/race (age in years, M, male; F, female, B, black; W, white).
bAttomolebenzolaJpyrene-diol epoxide(BPDE)/pg DNArecovered as BaP-
tetrol determinedonthree separateoccasions. (I, II, andIII represent materials
assayed from different portions ofthe same lung.)
CSNC serum not collected.
dND, not detected; below the limit ofdetection (6 pg BaP-tetrol/mL; 2 ug
cotinine/mL).
ePercent recovery of250-700amole/Ag BPDE-DNA.
ltg DNA (Table 1). Variation intheBPDE-DNA valuesobtain-
ed for someofthehumansamples isevident (samples 1132 and
1177); however, a similar variability was not observed for the
positive control materials (Table 1). Replicate DNA samples
were prepared from stored, frozen lung at different times;
thereforethesedata suggestheterogeneity ofadductlevels indif-
ferentpiecesofthesamelung. Nostatistical correlationbetween
serum cotinine levels and BPDE-DNA adduct levels was
observed in this small sample set.
These data show that mixtures ofPAH-DNA adducts canbe
isolated fromhuman DNAandcanbedetectedbySFS/FEEM.
This is because the antibodies used for IAC are specific for
PAH-DNAadducts, andSFS/FEEMyieldscharacteristic infor-
mationonaromaticnuclei. Thusfar, BPDE-DNAadductshave
beenshowntobepresentinadductmixturesisolatedfromhuman
lung. Thesestudiesarebeingextendedinfourmajordirections:
detection ofPAH-DNA adducts by SFS/FEEM may provide a
screening technique for asyetunknowncomponents ofcomplex
mixture samples; incombination with HPLC, attempts arebe-
ingmadetoidentify PAH-DNAadductsotherthanBPDE; other
tissues are being considered for the same adduct; the fluores-
cencetechniquesdescribedhere, incombination with IAC and
HPLC, may providecorroboration forless specific techniques
(enzyme immunoassays and the 32P-postlabeling assay).
This manuscript was presentedasaposterattheConferenceon Biomonitor-
ing and Susceptibility Markers in Human Cancer: Applications in Molecular
Epidemiology and RiskAssessment that was held in Kailua-Kona, Hawaii, 26
October-I November 1991.
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